Symptoms Of Depression clinical trials

Explore recruiting symptoms of depression clinical trials.

Recruiting symptoms of depression studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Symptoms Of Depression trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Randomized, Double blind, Placebo controlled Study to Evaluate the Effects of Oral NMRA-335140 versus Placebo in Participants with Major Depressive Disorder

Germany, Bulgaria, Czechia, France, Finland, Sweden +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase III, multicentre, randomised, double-blind, controlled study to investigate the efficacy, safety, and tolerability of two initial administrations of COMP360 in participants with treatment-resistant depression

France, Denmark, Sweden, Germany, Ireland, Netherlands +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

NBI-1065845-MDD3028: A Long-Term, Open-Label Study to Assess the Safety and Tolerability of NBI-1065845 as Adjunctive Treatment in Subjects with Major Depressive Disorder (MDD)

Bulgaria, Poland, Belgium, Croatia, Netherlands, Sweden +10 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Efficacy of psilocybin and trazodone combination in treatment-resistant depression: a randomized controlled proof-of-concept study (PSILOTRAZ)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

NBI-1065845-MDD3024: A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NBI-1065845 as Adjunctive Treatment in Subjects with Major Depressive Disorder (MDD)

Poland, Croatia, Czechia

Therapeutic confirmatory (Phase III) EU CTIS Study details

NBI-1065845-MDD3026: A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NBI-1065845 as Adjunctive Treatment in Subjects with Major Depressive Disorder (MDD)

Finland, Latvia, Belgium, Hungary

Therapeutic confirmatory (Phase III) EU CTIS Study details

Symptoms Of Depression trials by city

Symptoms Of Depression in Toronto Symptoms Of Depression in Vancouver Symptoms Of Depression in Montreal Symptoms Of Depression in Calgary Symptoms Of Depression in Edmonton Symptoms Of Depression in Ottawa Symptoms Of Depression in Winnipeg Symptoms Of Depression in Quebec City Symptoms Of Depression in Hamilton Symptoms Of Depression in Kitchener Symptoms Of Depression in London Symptoms Of Depression in Halifax Symptoms Of Depression in New York Symptoms Of Depression in Los Angeles Symptoms Of Depression in Chicago Symptoms Of Depression in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease